• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Chief Executive Officer Kohl Simeon

    5/5/25 9:31:23 PM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary
    Get the next $PHLT alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Kohl Simeon

    (Last) (First) (Middle)
    900 SOUTH PINE ISLAND ROAD
    SUITE 150

    (Street)
    PLANTATION FL 33324

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Performant Healthcare Inc [ PHLT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    05/01/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (1) 05/01/2025 A 198,320 (2) (2) Common Stock 198,320 (1) 198,320(2) D
    Restricted Stock Units (1) 05/01/2025 A 198,319 (3)(4)(5)(6)(7) (3)(4)(5)(6)(7) Common Stock 198,319 (1) 396,639(2)(3) D
    Explanation of Responses:
    1. Each restricted stock unit represents a contingent right to receive one share of PHLT's common stock. The units were awarded at no cost to the Reporting Person.
    2. Restricted Stock Unit Award was granted on May 1, 2025 (the "Grant Date"). The Restricted Stock Units will vest in four equal installments on the first day of the next open trading window immediately following the first, second, third and fourth anniversaries of the Grant Date provided that the Reporting Person remains in continuous service through each vest date, subject to vesting acceleration pursuant to the terms of the Reporting Person's Change in Control and Severance Agreement.
    3. Restricted Stock Unit Award was granted on May 1, 2025 (the "Grant Date"). These Restricted Stock Units shall vest over a four year period based upon continuous service through each vesting date and the trading price of the Company's Common Stock during the relevant vesting period, subject to accelerated vesting pursuant to the terms of the Reporting Person's Change in Control and Severance Agreement. Specifically, and subject to the vesting limitations described below, the trading price for Company's shares will need to be sustained for 60 consecutive trading days for one of the following vesting thresholds to have been met. Target Stock Price Hurdles are increases by year of +25%, +50%, +75%, and +100% versus initial stock price based on 60-day VWAP of $2.61 per share of one share on the Grant Date in each of the four years following the Grant Date.
    4. The vesting for the Restricted Stock Units and associated Stock Price Hurdles will be allocated into the following four tranches: (i) Tranche 1, 25% Vesting Percentage, $3.27 Stock Price Hurdle; (ii) Tranche 2, 50% Vesting Percentage, $3.92 Stock Price Hurdle; (iii) Tranche 3, 75% Vesting Percentage, $4.57 Stock Price Hurdle; and (iv) Tranche 4, 100% Vesting Percentage, $5.22 Stock Price Hurdle. The Restricted Stock Units within each Tranche will vest in accordance with the following: For Tranche 1, Reporting Person shall have up to three years to achieve the Stock Price Hurdle. If the Stock Price Hurdle is achieved before 12 months, Reporting Person vests in the Tranche 1 RSUs at 12 months. If the Stock Price Hurdle is achieved in month 13 - 36, Reporting Person vests in the Tranche 1 RSUs whenever the Stock Price Hurdle is achieved. If the Stock Price Hurdle is not achieved by 36 months, the RSUs tied to Tranche 1 are forfeited.
    5. For Tranche 2, Reporting Person shall have up to three years to achieve the Stock Price Hurdle. If the Stock Price Hurdle is achieved before 24 months, Reporting Person vests in the Tranche 2 RSUS at 24 months. If the Stock Price Hurdle is achieved in month 25 - 36, Reporting Person vests in the Tranche 2 RSUs whenever the Stock Price Hurdle is achieved. If the Stock Price Hurdle is not achieved by 36 months, the RSUs tied to Tranche 2 are forfeited.
    6. For Tranche 3, Reporting Person shall have up to four years to achieve the Stock Price Hurdle. If the Stock Price Hurdle is achieved before 36 months, Reporting Person vests in the Tranche 3 RSUs at 36 months. If the Stock Price Hurdle is achieved in month 37 - 48, Reporting Person vests in the Tranche 3 RSUs whenever the Stock Price Hurdle is achieved. If the Stock Price Hurdle is not achieved by 48 months, the RSUs tied to Tranche 3 are forfeited.
    7. For Tranche 4, Reporting Person shall have up to four years to hit the Stock Price Hurdle. If the Stock Price Hurdle is achieved before 48 months, Reporting Person vests in the Tranche 4 RSUs at 48 months. If the Stock Price Hurdle is not achieved by 48 months, the RSUs tied to Tranche 4 are forfeited.
    Remarks:
    /s/ Rohit Ramchandani, Attorney-in-Fact for Simeon M. Kohl 05/05/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $PHLT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PHLT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $PHLT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Performant Healthcare, Inc. Announces Financial Results for First Quarter 2025

      Performant Healthcare, Inc. (NASDAQ:PHLT), a leading provider of healthcare payment integrity services, today reported the following financial results for its first quarter ended March 31, 2025: First Quarter 2025 Financial Highlights Total revenue of $33.3 million, compared to total revenue of $27.3 million in the prior year period. Healthcare revenue of $33.2 million, compared to $25.8 million in the prior year period, an increase of approximately 29%. Net loss of $0.1 million, or $0.00 per diluted share, compared to net loss of $4.0 million, or $(0.05) per diluted share, in the prior year period. Adjusted EBITDA of $3.3 million, compared to $(1.2) million in the prior year perio

      5/8/25 4:00:00 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • Performant Healthcare, Inc. to Report First Quarter 2025 Earnings on May 8, 2025

      Performant Healthcare, Inc. (NASDAQ:PHLT) (the "Company", "Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that the company will report its first quarter 2025 results after the market closes Thursday May 8, 2025. The Company will also hold a conference call to discuss results at 5:00 pm (Eastern Time) that day. To join the conference call: Dial in 800-717-1738 or 646-307-1865, or Live webcast through company's website here Replay can be found approximately three hours after the call on the company website under the Events & Presentations section or by dialing 844-512-2921 (domestic), or 412-317-6671 (

      4/24/25 1:00:00 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • Performant Survey Spotlights Top Healthcare Technology Initiatives

      At HIMSS25, Performant Healthcare, Inc. (NASDAQ:PHLT) (the "Company" or "Performant"), a leader in technology-enabled payment integrity, eligibility and related analytics services, conducted a targeted survey of nearly 150 healthcare technology leaders to better understand the key drivers behind healthcare technology decision-making. The findings point to a healthcare landscape increasingly shaped by innovation, efficiency and the imperative to deliver better outcomes for patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250417442010/en/HIMSS25 Survey Highlights - Performant Healthcare Survey Key Findings: 61.5% of respo

      4/17/25 4:38:00 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary

    $PHLT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Performant Healthcare Inc.

      10-Q - Performant Healthcare Inc (0001550695) (Filer)

      5/9/25 5:15:15 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • Performant Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Performant Healthcare Inc (0001550695) (Filer)

      5/8/25 4:13:01 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • SEC Form DEFA14A filed by Performant Healthcare Inc.

      DEFA14A - Performant Healthcare Inc (0001550695) (Filer)

      4/25/25 8:24:54 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary

    $PHLT
    Financials

    Live finance-specific insights

    See more
    • Performant Healthcare, Inc. Announces Financial Results for First Quarter 2025

      Performant Healthcare, Inc. (NASDAQ:PHLT), a leading provider of healthcare payment integrity services, today reported the following financial results for its first quarter ended March 31, 2025: First Quarter 2025 Financial Highlights Total revenue of $33.3 million, compared to total revenue of $27.3 million in the prior year period. Healthcare revenue of $33.2 million, compared to $25.8 million in the prior year period, an increase of approximately 29%. Net loss of $0.1 million, or $0.00 per diluted share, compared to net loss of $4.0 million, or $(0.05) per diluted share, in the prior year period. Adjusted EBITDA of $3.3 million, compared to $(1.2) million in the prior year perio

      5/8/25 4:00:00 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • Performant Healthcare, Inc. to Report First Quarter 2025 Earnings on May 8, 2025

      Performant Healthcare, Inc. (NASDAQ:PHLT) (the "Company", "Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that the company will report its first quarter 2025 results after the market closes Thursday May 8, 2025. The Company will also hold a conference call to discuss results at 5:00 pm (Eastern Time) that day. To join the conference call: Dial in 800-717-1738 or 646-307-1865, or Live webcast through company's website here Replay can be found approximately three hours after the call on the company website under the Events & Presentations section or by dialing 844-512-2921 (domestic), or 412-317-6671 (

      4/24/25 1:00:00 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • Performant Healthcare, Inc. Announces Financial Results for Fourth Quarter and Full Year 2024

      Performant Healthcare, Inc. (NASDAQ:PHLT), a leading provider of healthcare payment integrity services, today reported the following financial results for its fourth quarter and full year ended December 31, 2024: Fourth Quarter 2024 Financial Highlights Total revenues of $34.8 million, compared to $32.6 million in the prior year period Healthcare revenues of $34.3 million, compared to $31.1 million in the prior year period Net loss of $0.5 million, or $(0.01) per diluted share, compared to net income of $1.3 million, or $0.02 per diluted share, in the prior year period Adjusted EBITDA of $3.1 million, compared to $4.5 million in the prior year period Adjusted net income of $1.3 m

      3/12/25 4:00:00 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary

    $PHLT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Chief Executive Officer Kohl Simeon

      4 - Performant Healthcare Inc (0001550695) (Issuer)

      5/5/25 9:31:23 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • SEC Form 4 filed by Chief Financial Officer Ramchandani Rohit

      4 - Performant Healthcare Inc (0001550695) (Issuer)

      5/5/25 9:29:28 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary